Cortechs.ai

Company Overview

Cortechs.ai develops and markets radiological software solutions that quantify and track neurodegeneration and cancers. Cortechs.ai’s brain imaging analysis helps neurologists, radiologists, oncologists, and clinical researchers quantify brain structures to assess a variety of neurological conditions, such as Alzheimer’s disease, glioblastomas, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities.

Cortechs.ai was founded in 1996 by Anders Dale and Eric Halgren. The company was incorporated in 2002 and by 2019, their products were used in 1,096 hospitals and imaging centers. They have customers across 14 countries. 

Cortechs.ai’s mission is to improve patient outcomes by empowering physicians to make more accurate and timely diagnostic decisions, combining cutting edge medical imaging with machine learning and clinical information to develop tools that better predict and diagnose disease. 

Modalities